CoChat

Calcium flux-independent NMDA receptor activity is required for Aβ oligomer-induced synaptic loss

Open access
Birnbaum, J H, Bali, J, Rajendran, L, Nitsch, R M, Tackenberg, C · 2015 · Cell Death & Disease
Cited by 98

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

Synaptic loss is one of the major features of Alzheimer’s disease (AD) and correlates with the degree of dementia. N-methyl-d-aspartate receptors (NMDARs) have been shown to mediate downstream effects of the β-amyloid peptide (A β) in AD models. NMDARs can trigger intracellular cascades via Ca 2+ entry, however, also Ca 2+-independent (metabotropic) functions of NMDARs have been described. We aimed to determine whether ionotropic or metabotropic NMDAR signaling is required for the induction of synaptic loss by A β. We show that endogenous A β as well as exogenously added synthetic A β oligomers induced dendritic spine loss and reductions in pre- and postsynaptic protein levels in hippocampal slice cultures. Synaptic alterations were mitigated by blocking glutamate binding to NMDARs using NMDAR antagonist APV, but not by preventing ion flux with Ca 2+ chelator BAPTA or open-channel blockers MK-801 or memantine. A β increased the activity of p38 MAPK, a kinase involved in long-term depression and inhibition of p38 MAPK abolished the loss of dendritic spines. A β-induced increase of p38 MAPK activity was prevented by APV but not by BAPTA, MK-801 or memantine treatment highlighting the role of glutamate binding to NMDARs but not Ca 2+ flux for synaptic degeneration by A β. We further show that treatment with the G protein inhibitor pertussis toxin (PTX) did not prevent dendritic spine loss in the presence of A β oligomers. Our data suggest that A β induces the activation of p38 MAPK and subsequent synaptic loss through Ca 2+ flux- and G protein-independent mechanisms.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/cddis.2015.160

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 28

  1. McLean CA, Cherny RA, Fraser FW, Fuller SJ, Smith MJ, Beyreuther K et al. Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann Neurol 1999; 46: 860–866. · doi:10.1002/1531-8249(199912)46:6<860::aid-ana8>3.0.co;2-m
  2. Shrestha BR, Vitolo OV, Joshi P, Lordkipanidze T, Shelanski M, Dunaevsky A et al. Amyloid beta peptide adversely affects spine number and motility in hippocampal neurons. Mol Cell Neurosci 2006; 33: 274–282. · DOI · Paper page
  3. Li S, Hong S, Shepardson NE, Walsh DM, Shankar GM, Selkoe D et al. Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron 2009; 62: 788–801. · DOI · Paper page
  4. Li S, Jin M, Koeglsperger T, Shepardson NE, Shankar GM, Selkoe DJ et al. Soluble Aß oligomers inhibit long-term potentiation through a mechanism involving excessive activation of extrasynaptic NR2B-containing NMDA receptors. J Neurosci 2011; 31: 6627–6638. · DOI · Paper page
  5. Chung C . NMDA receptor as a newly identified member of the metabotropic glutamate receptor family: clinical implications for neurodegenerative diseases. Mol Cells 2013; 36: 99–104. · DOI
  6. Nabavi S, Kessels HW, Alfonso S, Aow J, Fox R, Malinow R et al. Metabotropic NMDA receptor function is required for NMDA receptor-dependent long-term depression. Proc Natl Acad Sci USA 2013; 110: 4027–4032. · DOI · Paper page
  7. Vissel B, Krupp JJ, Heinemann S F, Westbrook GL . A use-dependent tyrosine dephosphorylation of NMDA receptors is independent of ion flux. Nat Neurosci 2001; 4: 587–596. · DOI · Paper page
  8. Nong Y, Huang YQ, Ju W, Kalia LV, Ahmadian G, Wang YT et al. Glycine binding primes NMDA receptor internalization. Nature 2003; 422: 302–307. · DOI · Paper page
  9. Kessels HW, Nabavi S, Malinow R . Metabotropic NMDA receptor function is required for β -amyloid – induced synaptic depression. Proc Natl Acad Sci USA 2013; 110: 4033–4038. · DOI · Paper page
  10. Wesemann W, Sturm G, Fünfgeld EW . Distribution of metabolism of the potential anti-parkinson drug memantine in the human. J Neural Transm Suppl 1980; 16: 143–148.
  11. Periclou A, Ventura D, Rao N, Abramowitz W . Pharmacokinetic study of memantine in healthy and renally impaired subjects. Clin Pharmacol Ther 2006; 79: 134–143. · DOI
  12. Hoey SE, Williams RJ, Perkinton MS . Synaptic NMDA receptor activation stimulates alpha-secretase amyloid precursor protein processing and inhibits amyloid-beta production. J Neurosci 2009; 29: 4442–4460. · DOI · Paper page
  13. Xia P, Chen HS, Zhang D, Lipton S A . Memantine preferentially blocks extrasynaptic over synaptic NMDA receptor currents in hippocampal autapses. J Neurosci 2010; 30: 11246–11250. · DOI · Paper page
  14. Bordji K, Becerril-Ortega J, Buisson A . Synapses, NMDA receptor activity and neuronal Aβ production in Alzheimer's disease. Rev Neurosci 2011; 22: 285–294. · DOI · Paper page
  15. Tanabe M, Gähwiler BH, Gerber U . Effects of transient oxygen-glucose deprivation on G-proteins and G-protein-coupled receptors in rat CA3 pyramidal cells in vitro. Europ J Neurosci 1998; 10: 2037–2045. · doi:10.1046/j.1460-9568.1998.00215.x
  16. Tamburri A, Dudilot A, Licea S, Bourgeois C, Boehm J . NMDA-receptor activation but not ion flux is required for amyloid-beta induced synaptic depression. Plos One 2013; 8: e65350. · DOI · Paper page
  17. Jensen L E, Bultynck G, Luyten T, Amijee H, Bootman MD, Roderick HL et al. Alzheimer's disease-associated peptide Aβ42 mobilizes ER Ca(2+) via InsP3R-dependent and -independent mechanisms. Front Mol Neurosci 2013; 6: 36. · DOI · Paper page
  18. Zhu Y, Pak D, Qin Y, McCormack SG, Kim MJ, Baumgart JP et al. Rap2-JNK removes synaptic AMPA receptors during depotentiation. Neuron 2005; 46: 905–916. · DOI · Paper page
  19. Huang CC, You JL, Wu MY, Hsu KS . Rap1-induced p38 mitogen-activated protein kinase activation facilitates AMPA receptor trafficking via the GDI.Rab5 complex. Potential role in (S)-3,5-dihydroxyphenylglycene-induced long term depression. J Biol Chem 2004; 279: 12286–12292. · DOI · Paper page
  20. Yang L, Mao L, Tang Q, Samdani S, Liu Z, Wang JQ et al. A novel Ca2+-independent signaling pathway to extracellular signal-regulated protein kinase by coactivation of NMDA receptors and metabotropic glutamate receptor 5 in neurons. J Neurosci 2004; 24: 10846–10857. · DOI · Paper page
  21. Hu N W, Nicoll AJ, Zhang D, Mably AJ, O'Malley T, Purro SA et al. mGlu5 receptors and cellular prion protein mediate amyloid-β-facilitated synaptic long-term depression in vivo. Nat Commun 2014; 5: 3374. · DOI · Paper page
  22. Harada J, Sugimoto M . An inhibitor of p38 and JNK MAP kinases prevents activation of caspase and apoptosis of cultured cerebellar granule neurons. Japn J Pharmacol 1999; 79: 369–378. · DOI · Paper page
  23. McLaughlin B, Pal S, Tran MP, Parsons AA, Barone FC, Erhardt JA et al. p38 activation is required upstream of potassium current enhancement and caspase cleavage in thiol oxidant-induced neuronal apoptosis. J Neurosci 2001; 21: 3303–3311. · DOI · Paper page
  24. Figueiredo CP, Clarke JR, Ledo JH, Ribeiro FC, Costa CV, Melo HM et al. Memantine rescues transient cognitive impairment caused by high-molecular-weight aβ oligomers but not the persistent impairment induced by low-molecular-weight oligomers. J Neurosci 2013; 33: 9626–9634. · DOI · Paper page
  25. Scheff SW, Price D A, Schmitt FA, DeKosky ST, Mufson EJ . Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. Neurology 2007; 68: 1507–1508. · DOI · Paper page
  26. Schneider LS, Dagerman KS, Higgins JP, McShane R . Lack of evidence for the efficacy of memantine in mild Alzheimer disease. Arch Neurol 2011; 68: 991–998. · DOI · Paper page
  27. Stoppini L, Buchs PA, Muller D . A simple method for organotypic cultures of nervous tissue. J Neurosci Methods 1991; 37: 173–182. · DOI · Paper page
  28. Klein WL . Abeta toxicity in Alzheimer's disease: globular oligomers (ADDLs) as new vaccine and drug targets. Neurochem Int 2002; 41: 345–352. · DOI · Paper page

Cited by

See all 98

Metadata

Authors
Birnbaum, J. H., Bali, J., Rajendran, L., Nitsch, R. M., & Tackenberg, C.
Venue
Cell Death & Disease
Published
2015-06-18
Volume
6
Issue
6
Pages
e1791-e1791
ISSN
2041-4889 (ISSN-L)
OpenAlex
W903670290
Cited by
98
References
15
FWCI
6.24
Type
journal article
Language
en
Open access
gold
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.